Iran in transition

被引：140

作者：

Danaei, Goodarz ^{[1
,2
,3
]}

Farzadfar, Farshad ^{[4
,5
]}

Kelishadi, Roya ^{[17
]}

Rashidian, Arash ^{[7
,18
]}

Rouhani, Omid M. ^{[19
]}

Ahmadnia, Shirin ^{[21
]}

Ahmadvand, Alireza ^{[4
]}

Arabi, Mandana ^{[3
,23
]}

Ardalan, Ali ^{[10
,24
]}

Arhami, Mohammad ^{[25
]}

Azizi, Mohammad Hossein ^{[26
]}

Bahadori, Moslem ^{[11
]}

Baumgartner, Jill ^{[20
]}

Beheshtian, Arash ^{[27
]}

Djalalinia, Shirin ^{[4
,28
]}

Doshmangir, Leila ^{[31
]}

Haghdoost, Ali Akbar ^{[32
]}

Haghshenas, Rosa ^{[4
]}

Hosseinpoor, Ahmad Reza ^{[33
]}

Islami, Farhad ^{[34
]}

Kamangar, Farin ^{[3
,35
]}

Khalili, Davood ^{[3
,36
]}

Madani, Kaveh ^{[39
,40
]}

Masoumi-Asl, Hossein ^{[29
,43
]}

Mazyaki, Ali ^{[22
,44
]}

Mirchi, Ali ^{[45
]}

Moradi, Ehsan ^{[19
]}

Nayernouri, Touraj ^{[12
]}

Niemeier, Debbie ^{[46
]}

Omidvari, Amir-Houshang ^{[41
]}

Peykari, Niloofar ^{[4
,30
]}

Pishgar, Farhad ^{[4
]}

Qorbani, Mostafa ^{[47
]}

Rahimi, Kazem ^{[3
,48
]}

Rahimi-Movaghar, Afarin ^{[13
]}

Tehrani, Fahimeh Ramezani ^{[37
]}

Rezaei, Nazila ^{[4
]}

Shahraz, Saeid ^{[3
,49
]}

Takian, Amirhossein ^{[8
]}

Tootee, Ali ^{[6
]}

Ezzati, Majid ^{[42
]}

Jamshidi, Hamid Reza ^{[38
]}

Larijani, Bagher ^{[5
]}

Majdzadeh, Reza ^{[9
,14
,15
,16
]}

Malekzadeh, Reza ^{[50
]}

机构：

[1] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA

[2] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA

[3] Sci Assoc Publ Hlth Iran, Boston, MA USA

[4] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Endocrinol & Metab Populat Sci Inst, Tehran, Iran

[5] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran

[6] Univ Tehran Med Sci, Diabet Res Ctr, Tehran, Iran

[7] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Dept Hlth Management & Econ, Tehran, Iran

[8] Univ Tehran Med Sci, Dept Global Hlth & Publ Policy, Tehran, Iran

[9] Univ Tehran Med Sci, Dept Epidemiol & Biostat, Tehran, Iran

[10] Univ Tehran Med Sci, Sch Publ Hlth, Tehran, Iran

[11] Univ Tehran Med Sci, Fac Med, Tehran, Iran

[12] Univ Tehran Med Sci, Dept Neurosci, Sch Adv Med Technol, Tehran, Iran

[13] Univ Tehran Med Sci, Iranian Natl Ctr Addict Studies, Tehran, Iran

[14] Univ Tehran Med Sci, Knowledge Utilizat Res Ctr, Tehran, Iran

[15] Univ Tehran Med Sci, Community Based Participatory Res Ctr, Tehran, Iran

[16] Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Ctr, Digest Dis Res Inst, Tehran, Iran

[17] Isfahan Univ Med Sci, Res Inst Primordial Prevent Noncommunicable Dis, Child Growth & Dev Res Ctr, Esfahan, Iran

[18] WHO, Dept Informat Evidence & Res, Eastern Mediterranean Reg Off, Cairo, Egypt

[19] McGill Univ, Dept Civil Engn & Appl Mech, Montreal, PQ, Canada

[20] McGill Univ, Inst Hlth & Social Policy, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada

[21] Allameh Tabatabai Univ, Fac Social Sci, Tehran, Iran

[22] Allameh Tabatabai Univ, Dept Econ, Tehran, Iran

[23] Global Alliance Improving Nutr, New York, NY USA

[24] Harvard Humanitarian Initiat, Cambridge, MA USA

[25] Sharif Univ Technol, Dept Civil Engn, Tehran, Iran

[26] Acad Med Sci IR Iran, Tehran, Iran

[27] Cornell Univ, Cornell Program Infrastruct Policy, Ithaca, NY USA

[28] Minist Hlth & Med Educ, Deputy Res & Technol, Tehran, Iran

[29] Minist Hlth & Med Educ, Ctr Communicable Dis, Tehran, Iran

[30] Minist Hlth & Med Educ, Tehran, Iran

[31] Tabriz Univ Med Sci, Hlth Serv Management Res Ctr, Sch Management & Med Informat, Iranian Ctr Excellence Hlth Management, Tabriz, Iran

[32] Kerman Univ Med Sci, Modeling Hlth Res Ctr, Inst Futures Studies Hlth, Kerman, Iran

[33] WHO, Dept Informat Evidence & Res, Geneva, Switzerland

[34] Amer Canc Soc, Surveillance & Hlth Serv Res, Atlanta, GA 30329 USA

[35] Morgan State Univ, Dept Biol, Sch Comp Math & Nat Sci, Baltimore, MD 21239 USA

[36] Shahid Beheshti Univ Med Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran

[37] Shahid Beheshti Univ Med Sci, Reprod Endocrinol Res Ctr, Tehran, Iran

[38] Shahid Beheshti Univ Med Sci, Sch Med, Res Inst Endocrine Sci, Tehran, Iran

[39] Stockholm Univ, Dept Phys Geog, Stockholm, Sweden

[40] Imperial Coll London, Ctr Environm Policy, London, England

[41] Imperial Coll London, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England

[42] Imperial Coll London, MRC PHE Ctr Environm & Hlth, London, England

[43] Iran Univ Med Sci, Res Ctr Pediat Infect Dis, Inst Immunol & Infect Dis, Tehran, Iran

[44] Inst Management & Planning Studies, Tehran, Iran

[45] Oklahoma State Univ, Dept Biosyst & Agr Engn, Stillwater, OK 74078 USA

[46] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA

[47] Alborz Univ Med Sci, Noncommunicable Dis Res Ctr, Karaj, Iran

[48] Univ Oxford, George Inst Global Hlth, Oxford, England

[49] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA

[50] Shiraz Univ Med Sci, Noncommunicable Dis Res Ctr, Shiraz, Iran

来源：

LANCET | 2019年 / 393卷 / 10184期

关键词：

PRIMARY-HEALTH-CARE; CANON-OF-MEDICINE; BODY-MASS INDEX; SYSTEMATIC ANALYSIS; POOLED ANALYSIS; GLOBAL BURDEN; BRIEF-HISTORY; RISK-FACTORS; PREVALENCE; ERADICATION;

D O I：

10.1016/S0140-6736(18)33197-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Being the second-largest country in the Middle East, Iran has a long history of civilisation during which several dynasties have been overthrown and established and health-related structures have been reorganised. Iran has had the replacement of traditional practices with modern medical treatments, emergence of multiple pioneer scientists and physicians with great contributions to the advancement of science, environmental and ecological changes in addition to large-scale natural disasters, epidemics of multiple communicable diseases, and the shift towards non-communicable diseases in recent decades. Given the lessons learnt from political instabilities in the past centuries and the approaches undertaken to overcome health challenges at the time, Iran has emerged as it is today. Iran is now a country with a population exceeding 80 million, mainly inhabiting urban regions, and has an increasing burden of non-communicable diseases, including cardiovascular diseases, hypertension, diabetes, malignancies, mental disorders, substance abuse, and road injuries.

引用

页码：1984 / 2005

页数：22

共 173 条

[1] Abbasi-Ghahramanloo Abbas, 2015, Int J High Risk Behav Addict, V4, pe21945, DOI 10.5812/ijhrba.21945
[2] CAUSES OF THE CONSTITUTIONAL REVOLUTION IN IRAN
ABRAHAMIAN, E
[J]. INTERNATIONAL JOURNAL OF MIDDLE EAST STUDIES, 1979, 10 (03) : 381 - 414
[3] A Brief Report About the Concepts of Hand Disorders in the Canon of Medicine of Avicenna
Afshar, Ahmadreza
[J]. JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 2011, 36A (09): : 1509 - 1514
[4] Unprotected Sex with Injecting Drug Users among Iranian Female Sex Workers: Unhide HIV Risk Study
Ahmadi, Khodabakhsh
Rezazade, Majid
Nafarie, Mohammad
Moazen, Babak
Vasel, Mosaieb Yarmohmmadi
Assari, Shervin
[J]. AIDS RESEARCH AND TREATMENT, 2012, 2012
[5] Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey
Amin-Esmaeili, Masoumeh
Rahimi-Movaghar, Afarin
Sharifi, Vandad
Hajebi, Ahmad
Radgoodarzi, Reza
Mojtabai, Ramin
Hefazi, Mitra
Motevalian, Abbas
[J]. ADDICTION, 2016, 111 (10) : 1836 - 1847
[6] [Anonymous], 2007, IRAN J PSYCHIAT
[7] [Anonymous], J AM SCI
[8] [Anonymous], HLTH SERV UT
[9] [Anonymous], 1926, LANCET
[10] [Anonymous], GEOGRAPHICAL DISTRIB

← 1 2 3 4 5 6 7 8 9 10 →